BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26158404)

  • 1. Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules.
    Urick AK; Hawk LM; Cassel MK; Mishra NK; Liu S; Adhikari N; Zhang W; dos Santos CO; Hall JL; Pomerantz WC
    ACS Chem Biol; 2015 Oct; 10(10):2246-56. PubMed ID: 26158404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorinated aromatic amino acids are sensitive 19F NMR probes for bromodomain-ligand interactions.
    Mishra NK; Urick AK; Ember SW; Schönbrunn E; Pomerantz WC
    ACS Chem Biol; 2014 Dec; 9(12):2755-60. PubMed ID: 25290579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New inhibitors for the BPTF bromodomain enabled by structural biology and biophysical assay development.
    Ycas PD; Zahid H; Chan A; Olson NM; Johnson JA; Talluri SK; Schonbrunn E; Pomerantz WCK
    Org Biomol Chem; 2020 Jul; 18(27):5174-5182. PubMed ID: 32588860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of selective BPTF bromodomain inhibitors by screening and structure-based optimization.
    Xiong L; Mao X; Guo Y; Zhou Y; Chen M; Chen P; Yang S; Li L
    Biochem Biophys Res Commun; 2021 Mar; 545():125-131. PubMed ID: 33548625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunity knocks for uncovering the new function of an understudied nucleosome remodeling complex member, the bromodomain PHD finger transcription factor, BPTF.
    Zahid H; Olson NM; Pomerantz WCK
    Curr Opin Chem Biol; 2021 Aug; 63():57-67. PubMed ID: 33706239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of novel ligand targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery: complete pharmacophore approach.
    Shanmugam V; Muthukrishnan S
    J Biomol Struct Dyn; 2023; 41(23):14524-14539. PubMed ID: 36841551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity, ligand deconstruction, and cellular activity analysis of a BPTF bromodomain inhibitor.
    Kirberger SE; Ycas PD; Johnson JA; Chen C; Ciccone MF; Woo RWL; Urick AK; Zahid H; Shi K; Aihara H; McAllister SD; Kashani-Sabet M; Shi J; Dickson A; Dos Santos CO; Pomerantz WCK
    Org Biomol Chem; 2019 Feb; 17(7):2020-2027. PubMed ID: 30706071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Design Rules for Developing Potent Cell-Active Inhibitors of the Nucleosome Remodeling Factor (NURF) via BPTF Bromodomain Inhibition.
    Zahid H; Buchholz CR; Singh M; Ciccone MF; Chan A; Nithianantham S; Shi K; Aihara H; Fischer M; Schönbrunn E; Dos Santos CO; Landry JW; Pomerantz WCK
    J Med Chem; 2021 Sep; 64(18):13902-13917. PubMed ID: 34515477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the Selectivity of Protein-Protein and Small Molecule Interactions with Fluorinated Tandem Bromodomain Reader Proteins.
    Kalra P; McGraw L; Kimbrough JR; Pandey AK; Solberg J; Cui H; Divakaran A; John K; Hawkinson JE; Pomerantz WCK
    ACS Chem Biol; 2020 Nov; 15(11):3038-3049. PubMed ID: 33138352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT.
    Yu Z; Ku AF; Anglin JL; Sharma R; Ucisik MN; Faver JC; Li F; Nyshadham P; Simmons N; Sharma KL; Nagarajan S; Riehle K; Kaur G; Sankaran B; Storl-Desmond M; Palmer SS; Young DW; Kim C; Matzuk MM
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33637650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAR by (Protein-Observed)
    Divakaran A; Kirberger SE; Pomerantz WCK
    Acc Chem Res; 2019 Dec; 52(12):3407-3418. PubMed ID: 31718149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Protein- and Ligand-Observed NMR Workflow to Screen Fragment Cocktails against Multiple Proteins: A Case Study Using Bromodomains.
    Johnson JA; Olson NM; Tooker MJ; Bur SK; Pomerantz WCK
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32872491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability.
    Jennings LE; Schiedel M; Hewings DS; Picaud S; Laurin CMC; Bruno PA; Bluck JP; Scorah AR; See L; Reynolds JK; Moroglu M; Mistry IN; Hicks A; Guzanov P; Clayton J; Evans CNG; Stazi G; Biggin PC; Mapp AK; Hammond EM; Humphreys PG; Filippakopoulos P; Conway SJ
    Bioorg Med Chem; 2018 Jul; 26(11):2937-2957. PubMed ID: 29776834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmental Isotope Labelling of an Individual Bromodomain of a Tandem Domain BRD4 Using Sortase A.
    Williams FP; Milbradt AG; Embrey KJ; Bobby R
    PLoS One; 2016; 11(4):e0154607. PubMed ID: 27128490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds.
    Yu JL; Chen TT; Zhou C; Lian FL; Tang XL; Wen Y; Shen JK; Xu YC; Xiong B; Zhang NX
    Acta Pharmacol Sin; 2016 Jul; 37(7):984-93. PubMed ID: 27238211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen.
    Ayoub AM; Hawk LML; Herzig RJ; Jiang J; Wisniewski AJ; Gee CT; Zhao P; Zhu JY; Berndt N; Offei-Addo NK; Scott TG; Qi J; Bradner JE; Ward TR; Schönbrunn E; Georg GI; Pomerantz WCK
    J Med Chem; 2017 Jun; 60(12):4805-4817. PubMed ID: 28535045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased multicomponent reactions to develop novel bromodomain inhibitors.
    McKeown MR; Shaw DL; Fu H; Liu S; Xu X; Marineau JJ; Huang Y; Zhang X; Buckley DL; Kadam A; Zhang Z; Blacklow SC; Qi J; Zhang W; Bradner JE
    J Med Chem; 2014 Nov; 57(21):9019-27. PubMed ID: 25314271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-Observed Fluorine NMR Is a Complementary Ligand Discovery Method to
    Urick AK; Calle LP; Espinosa JF; Hu H; Pomerantz WC
    ACS Chem Biol; 2016 Nov; 11(11):3154-3164. PubMed ID: 27627661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of High-Affinity Inhibitors of the BPTF Bromodomain.
    Lu T; Lu H; Duan Z; Wang J; Han J; Xiao S; Chen H; Jiang H; Chen Y; Yang F; Li Q; Chen D; Lin J; Li B; Jiang H; Chen K; Lu W; Lin H; Luo C
    J Med Chem; 2021 Aug; 64(16):12075-12088. PubMed ID: 34375106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided design.
    Duffy BC; Liu S; Martin GS; Wang R; Hsia MM; Zhao H; Guo C; Ellis M; Quinn JF; Kharenko OA; Norek K; Gesner EM; Young PR; McLure KG; Wagner GS; Lakshminarasimhan D; White A; Suto RK; Hansen HC; Kitchen DB
    Bioorg Med Chem Lett; 2015 Jul; 25(14):2818-23. PubMed ID: 26022843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.